Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The protein structure of GLP-1 receptor agonists is fragile
Secondary outcomes included the use of rescue medication, exposure to inhaled corticosteroids and chest infection events, defined by prescription redemption for antibiotics commonly used to treat lower airway infections
According to the terms of the agreement, Eli Lilly will obtain exclusive, target specific rights to Ascidian's RNA exon editing technology for undisclosed kidney disease targets
IPO processes from 2022-2024
*Individual results vary
US$ 20.35
US$ 25.02
US$ 24.97
US$ 21.97
US$ 21.94
US$ 24.00
US$ 21.49
